Le Lézard
Classified in: Business
Subject: CALENDAR OF EVENTS

Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024


NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum to be held March 7th. This event is sponsored by Zacks Small-Cap Research. Individual investors, institutional investors, advisors, and analysts are invited to attend.

REGISTER NOW AT: https://bit.ly/430WqL8

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations and schedule 1x1 meetings with management.

"We're pleased to feature today's innovators at our upcoming Life Sciences Virtual Investor Conference," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "We thank Zacks Small-Cap Research for their sponsorship and collaboration on this unique event."

March 7th

Eastern
Time (ET)		PresentationTicker(s)
10:00 AMGenFlow Biosciences PlcOTCQB: GENFF | LSE: GENF
10:30 AMLisata Therapeutics, Inc.Nasdaq: LSTA
11:00 AM Kiromic BioPharma, Inc.OTCQB: KRBP
11:30 AM Syra Health Corp.Nasdaq: SYRA
12:30 PMAlpha Cognition Inc.OTCQB: ACOGF | CSE: ACOG
1:00 PM Achieve Life Sciences, Inc.NASDAQ: ACHV


To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact: 
OTC Markets Group Inc. +1 (212) 896-4428, [email protected]

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected] 



These press releases may also interest you

at 06:35
Ault Alliance Reports Preliminary Revenue of $36 Million for First Quarter 2024
Ault Alliance, Inc. , a diversified holding company ("Ault Alliance," or the "Company"), today announced preliminary revenue of $36 million for the first quarter of 2024, the highest first quarter topline results in the Company's history. The...

at 06:31
Qudian Files Its Annual Report on Form 20-F
Qudian Inc. ("Qudian" or "the Company" or "We") , a consumer-oriented technology company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April...

at 06:30
AirBoss Awarded Bandolier Contract Valued at up to US$45 million
AirBoss of America Corp. (the "Company" or "AirBoss") today announced that its wholly-owned subsidiary, AirBoss Defense Group ("ADG"), has been awarded a contract valued at up to US$45 million to provide its Bandolier lightweight, multipurpose...

at 06:30
Daqo New Energy Announces Unaudited First Quarter 2024 Results
Daqo New Energy Corp. ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced its unaudited financial results for the first quarter of 2024. First Quarter 2024...

at 06:30
Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due...

at 06:17
Local Infusion Opens Infusion Center in New Haven, Connecticut, the Seventh Location to Open in New England
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in New Haven, Connecticut. We are excited about our continued...

More news about Business...


News published on and distributed by: